Success Stories: In Just 2 Months, Our Team of Experts Won NIW Approval for a Japanese Postdoctoral Research Fellow in Molecular Biology


Client’s Testimonial:

“I am truly grateful for all of your support.”

On April 25th, 2022, we received another EB-2 NIW (National Interest Waiver) approval for a Postdoctoral Research Fellow in the Field of Molecular Biology (Approval Notice).

General Field: Molecular Biology

Position at the Time of Case Filing: Postdoctoral Research Fellow

Country of Origin: Japan

State of Residence at the Time of Filing: Maryland

Approval Notice Date: April 25th, 2022

Processing Time: 2 months, 3 days

Case Summary:

“Prostate cancer is among the most prevalent diseases in the world for aging males, the second most common type of cancer in men overall, and the fifth leading cause of death worldwide. [The client], a molecular biology researcher specializing in prostate cancer whose novel developments in the diagnosis and treatment of mCRPC have already made significant and highly valuable contributions to the field.”

“In the United States, prostate cancer is a highly prevalent disease that affects one in eight men in their lifetimes and currently represents the second leading cause of cancer deaths among men. [The client’s] work directly addresses these critical concerns through the development of novel non-invasive biomarker detection and treatment protocols. These developments allow for individualized treatments for mCRPC patients, which results in improved patient outcomes and enhanced quality of life.”

These are two selected passages from letters of recommendation written for a postdoctoral research fellow in molecular biology from Japan. She held a Ph.D. in urology and wanted to continue her work in the United States for which she needed to file an NIW (National Interest Waiver) petition. Our team signed the retainer agreement with her, collected information from her academic and professional documents, and found the following:

  • As an expert in the field of molecular biology, her proposed endeavor is to continue to develop liquid-based, non-invasive biomarker identification and cancer treatment strategies to advance innovations in the care of prostate cancer patients.
  • Her research is of great importance because it addresses one of the world’s primary health concerns. Prostate cancer is known to be the fourth most common cancer throughout the global population and the second most common in men.
  • Her research also improves the methodologies for detecting and treating prostate cancer, thereby improving the length and quality of life for the patients and reducing associated expenses.
  • Her proposed endeavor also has broad implications for the United States, since, in America alone, nearly 250,000 new cases of prostate cancer are diagnosed each year. Furthermore, more than 34,000 Americans lose their lives to this disease, cementing prostate cancer as the second leading cause of cancer death among American men.
  • Her research contributes to earlier detection technologies and improves treatment strategies for standard and mCRPC patients, increasing the lifespan of the millions of U.S. citizens suffering from prostate cancer. Her research directly supports national efforts to minimize the incidence and mortality of prostate cancer, revealing that it holds immense and immediate applicability in promoting national health outcomes.
  • She has completed at least 9 reviews to date, and her work has resulted in 16 peer-reviewed journal articles (5 of them first-authored) and 1 book chapter.
  • These publications have been cited a total of 190 times according to Google Scholar.
  • Finally, her work in the area has stretched to over 12 years which means that she holds vast experience in the area.

These pieces of evidence thus helped us to show that her research on prostate cancer treatments holds significant value for U.S. public health, considering that millions of Americans require treatment for prostate cancer each year. This is exactly what won her approval. We are glad to have worked with her and won this case. We send our warmest regards and wish her the best in future endeavors.

North America Immigration Law Group (Chen Immigration Law Associates) is a U.S. immigration law firm dedicated to representing corporations, research institutions, and individuals from all 50 U.S. states regarding I-140 immigration petitions. We specialize in employment-based immigration petition and have a proven record of high success rate for the categories of: EB2-NIW (National Interest Waiver), EB1-A (Alien of Extraordinary Ability), EB1-B (Outstanding Researcher/Professor) and O-1 (Alien of Extraordinary Ability).

Our Ten Thousand I-140 Approvals Provide Unprecedented Insight into the USCIS Adjudication Trend

With more than 16,000 EB-1A, EB-1B, EB-2 NIW and O-1 cases approved, we have first hand information on the manner in which the USCIS adjudicate I-140 cases. As the USCIS has constantly changed its adjudication standards for the EB-1A, EB-1B and EB-2 NIW categories, our firm's huge database of successful cases gives you unprecedented insight to USCIS adjudication trends. We carefully analyze the data for all of our cases and apply the results of our analyses toward giving our clients up-to-date advice and adapting our strategies such that we remain on par with the ever-shifting landscape of immigration law in the U.S. With us, you will always have access to important updates, strategies, and information so that you can make the most informed decisions about your case.

We Have Helped Hundreds and Thousands of Clients with Credentials and Backgrounds Similar to Yours

With our exceedingly large number of successful petitions, no matter what credentials you have, no matter your background and field of expertise, no matter your visa status or nationality, chances are we have helped hundreds or even thousands of clients just like you. Our clients are usually impressed with how well we understand their research and work. Our insight and understanding stems from the fact that we have handled many cases with elements similar to yours already, and this helps us devise the best strategies for each individual petition.

Vast Majority of Clients Came to Us Because of Referrals

For years, our firm has attracted new clients based solely on word of mouth, recommendations, and the positive collaboration experiences shared with them by their friends and family. We take pride in our reputation and work hard to ensure that we provide a green card application experience that our clients are happy to share with their friends and colleagues. That is how our approved cases grew from 600 in 2013 to over 3,500 in 2019.

If you are interested in filing the green card, please send your CV to for our free evaluation. Our attorneys will email you back with the evaluation result within 24 hours.

Approval Notices:

Success Stories:


Free evaluation email:

Tel: 888.666.0969 (Toll Free)

To see more clients’ testimonials and approvals, please refer to:

Client's Testimonials

Approval Notices

To Learn More About Your Options CLICK HERE

Copyright © North America Immigration Law, All Rights Reserved.